Please join your NAVREF colleagues for a conference call with Eugene
Patin, RPh, National Director, IDTI, RDI, Novartis Clinical Operations
in Canton, Michigan. Learn how to optimize VA PI and NPC involvement in
Novartis clinical trials. After discussing evolving trends in clinical
trials and the challenges that must be met to ensure successful trials
and site relationships, Mr. Patin will discuss upcoming opportunities
for VA sites to work with Novartis, maximizing use of the first master
CRADA to be successfully executed between VA and a major pharmaceutical
company.
Date: Monday, July 20, 2009
Time: 3:00 p.m. EDT
Dial: 877-643-6951
Passcode: 1051-0072
Program:
3:00 - Brief Welcome by NAVREF Chair Donna McCartney
3:05 - Novartis Presentation – Eugene Patin, RPh. National Director,
IDTI, RDI, Novartis Clinical Operations, Canton, MI
3:45 - Questions
4:00 Call ends not later than 4:00
Please
note:
This call is intended only for NAVREF members and individuals directly
associated with NPCs.
|
|
|
Questions or comments about this Update may be directed to:
Email:
navref@navref.org
|
Phone: 301-656-5005 |
Fax: 301-656-5008 |
|